Precigen, Inc.
PGEN
$3.71
$0.143.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 651.20% | 147.31% | 59.90% | -0.85% | -22.37% |
| Total Other Revenue | -253.33% | -- | 40.00% | 44.00% | -11.76% |
| Total Revenue | 652.08% | 146.73% | 59.20% | -1.12% | -22.76% |
| Cost of Revenue | -18.21% | -17.46% | -50.42% | -44.10% | -51.72% |
| Gross Profit | 99.55% | 34.14% | 56.16% | 47.03% | 53.82% |
| SG&A Expenses | 81.19% | 69.83% | 56.52% | 23.57% | 11.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.23% | 17.90% | 14.76% | -0.63% | 1.89% |
| Operating Income | 3.11% | -12.56% | -12.91% | 0.61% | -3.38% |
| Income Before Tax | -29.04% | -95.77% | -74.40% | 9.36% | -62.74% |
| Income Tax Expenses | 100.17% | 100.17% | 95.88% | 96.50% | -308.33% |
| Earnings from Continuing Operations | -30.49% | -98.55% | -76.88% | 8.04% | -61.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.49% | -98.55% | -76.88% | 8.04% | -61.65% |
| EBIT | 3.11% | -12.56% | -12.91% | 0.61% | -3.38% |
| EBITDA | 3.36% | -14.66% | -16.77% | -3.70% | -7.23% |
| EPS Basic | -116.59% | -190.15% | -155.65% | 20.77% | -46.69% |
| Normalized Basic EPS | -42.42% | -122.20% | -116.83% | -15.29% | -29.58% |
| EPS Diluted | -116.59% | -190.15% | -155.65% | 20.77% | -46.69% |
| Normalized Diluted EPS | -42.42% | -122.20% | -116.83% | -15.29% | -29.58% |
| Average Basic Shares Outstanding | 17.66% | 16.92% | 16.00% | 16.05% | 12.13% |
| Average Diluted Shares Outstanding | 17.66% | 16.92% | 16.00% | 16.05% | 12.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |